Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Avril

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
Clinical Genetics|March 17, 2017
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriersM Muller, S Ferlicot, M Guillaud-Bataille, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patientsM A Richard, J J Grob, M F Avril, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctorsM A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
Clinical Genetics|March 17, 2017
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriersM Muller, S Ferlicot, M Guillaud-Bataille, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patientsM A Richard, J J Grob, M F Avril, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctorsM A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
Pageof 20